Member Info for xviolet

9.75 paid.

Bring on round 2.
Not for the faint hearted this one!

Sorry to ask but does anyone know how to easily buy shares in CSE EATS? EatBeyond Global Not available on HL.
Thanks.

Bought a few more this AM. Then watched price go down.
But don't mind 2 much. I have thought about an HE1 trading range that makes sense for me.
And thats it really.

It seems worth trying to make the distinction between the market/need for therapeutics and the degree of success that SAR could have in that market. The former is a straightforwards case, I think. The latter is more interesting to research.

Willibo

I can't help feeling increasingly confident about SYN. Have been doing well in SAR recently but the latter may more be hyped/puffed at the moment - and SYN more solid and less likely, bad news notwithstanding, to slide.

I still have HIVE on my watchlist.

Seaboy

thanks. beautiful writing.
very helpful post. thanks again.

'potentially vaccs evasive.'
however a secondary issue relates to severity or non-severity of resulting infection.

we need to think about/be aware of both of these points.

Prion25

thanks for the link.

SalaciousC

Ah thanks for that. I stumbled across his blog and was beginning to think 'OMG this guy is good!' So thank you for the confirmation. Its hard to find good sources and guides.

maidit308

thanks for taking the time to respond.
and yes that fella's article is quite stimulating!

SOG

Thank you for your considered and helpful reply. For me there is so much work to do to understand the science in this field. So again thanks for some good pointers I can use - for me I can get swept away with the fantasy of a share but I know its important to ground that in reality - but the reality here...is complex! science, pharma etc. But anyway thanks for the reply.

this fella lays into merck (no idea if he's right or not).
https://blogs.sciencemag.org/pipeline/archives/2021/04/15/merck-keeps-plowing-on

this fella a bit skeptical on merck....
https://blogs.sciencemag.org/pipeline/archives/2021/04/15/merck-keeps-plowing-on

And sorry if I missed our posts on Molnupiravir and this is an old tired story on this board. If I missed the posts - sorry.

Molnupiravir/Merck. pharma heavyweight effort incoming
have we already covered Molnupiravir on this board? have we uncovered any science or research to knock Merck out of the game? or at least down a few pegs.

Doc

cheers. thanks for the lovely clear and sane response
have a good w/end.

Does the fact the Delta variant is more contagious than previous variants increase the chances of the USA issuing an EUA for SYN? Un-answerable until it happens. But Delta is different. And maybe different enough to prompt a new response. Especially in the USA where Govt is concerned about numbers of unvaccinated being vulnerable to Delta - and I imagine this is all happening now - as in hour by hour because Delta moves very quickly.

yeah. everyone's at lunch or something. except all the people buying...does look like a lot of buys coming in.